Approval · Notice of Compliance 18712 · 2016
ANDRODERM: Notice of Compliance 18712
Issued November 24, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18712
- Date
- November 24, 2016
- Company
- Allergan Pharma Co.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
Medicinal ingredients
- TESTOSTERONE 12.2 MG per PATCH
- TESTOSTERONE 24.3 MG per PATCH